Suppr超能文献

鼻瓣膜塌陷患者中LATERA可吸收鼻植入物与手术修复的全因索赔分析。

All-cause claims analysis of the LATERA absorbable nasal implant vs surgical repair in patients with nasal valve collapse.

作者信息

Vo Ricky, Barhoush Yazid, Batchu Lakshmi, Adams Shayna, Setzen Gavin

机构信息

Medical Affairs, Stryker ENT, Plymouth, Minnesota, USA.

STATinMED LLC, Dallas, Texas, USA.

出版信息

J Med Econ. 2024 Jan-Dec;27(1):1099-1107. doi: 10.1080/13696998.2024.2362046. Epub 2024 Aug 23.

Abstract

AIMS

To compare all-cause claims associated with the LATERA Absorbable Nasal Implant and surgical repair of nasal vestibular stenosis in patients with nasal valve collapse.

METHODS

This retrospective cohort study utilized data from STATinMED RWD Insights. A defined set of HCPCS, ICD-10-CM and CPT codes were used to identify patients with ≥1 claim for a LATERA procedure, and patients with ≥1 claim for surgical repair between June 1, 2015- March 31, 2023. Patients with continuous capture for at least 12 months before and at least 6 months after the index date were selected. The index date was defined as earliest date of encounter for a LATERA or surgical repair procedure. Inverse probability of treatment weighting (IPTW) was used to ensure balance between cohorts. Descriptive analyses were provided for all claims data using standard summary statistics. All-cause claims were assessed during the baseline, index date, and follow-up period. Chi-squared tests and independent sample t-tests were used to assess differences in cohorts for categorical and continuous variables, respectively.

RESULTS

The study population included 5,032 LATERA patients and 26,553 surgical repair patients. During the baseline and follow-up periods, the matched cohorts exhibited similar all-cause claims. On the index date, LATERA patients incurred lower claims vs. surgical repair, likely due to LATERA's ability to be implanted in the physician office setting. LATERA patients and surgical repair patients mean (SD) total costs were $9,612 [$14,930] vs $11,846 [$17,037] ( ≤ 0.0001), respectively.

CONCLUSIONS

Treatment with the LATERA Absorbable Nasal Implant is a potentially cost saving option for payers on the index date compared to traditional surgical repair in patients with nasal valve collapse due to the ability to be performed in the office. All-cause claims were similar in the baseline and follow-up periods. When performed with concomitant procedures, all-cause claims during follow-up were similar between groups.

摘要

目的

比较与LATERA可吸收鼻植入物相关的全因索赔以及鼻瓣膜塌陷患者鼻前庭狭窄的手术修复情况。

方法

这项回顾性队列研究利用了STATinMED RWD Insights的数据。使用一组定义好的医疗保健通用程序编码系统(HCPCS)、国际疾病分类第十版临床修正版(ICD-10-CM)和现行程序编码(CPT)代码来识别接受过至少1次LATERA手术索赔的患者,以及在2015年6月1日至2023年3月31日期间接受过至少1次手术修复索赔的患者。选择在索引日期前至少连续记录12个月且索引日期后至少连续记录6个月的患者。索引日期定义为首次进行LATERA或手术修复程序的最早日期。使用治疗加权逆概率(IPTW)来确保队列之间的平衡。使用标准汇总统计数据对所有索赔数据进行描述性分析。在基线期、索引日期和随访期评估全因索赔。分别使用卡方检验和独立样本t检验来评估分类变量和连续变量在队列中的差异。

结果

研究人群包括5032名接受LATERA治疗的患者和26553名接受手术修复的患者。在基线期和随访期,匹配的队列显示出相似的全因索赔。在索引日期,接受LATERA治疗的患者的索赔低于手术修复患者,这可能是由于LATERA能够在医生办公室环境中植入。接受LATERA治疗的患者和接受手术修复的患者的平均(标准差)总成本分别为9612美元[14930美元]和11846美元[17037美元](P≤0.0001)。

结论

与传统手术修复相比,对于鼻瓣膜塌陷患者,由于LATERA可吸收鼻植入物能够在办公室进行,在索引日期对支付方来说可能是一种潜在的节省成本的选择。在基线期和随访期,全因索赔相似。当与其他手术同时进行时,随访期间两组的全因索赔相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验